Applied Research on drugs and vaccines against parasitic diseases
Abstract
This effort assesses and improves on candidate drugs coming from the DoD discovery program and from other collaborations for prevention and treatment of malaria; to counter the continuing spread of drug resistance to current drugs; assesses currently available drugs for use against cutaneous leishmaniasis (a skin-based disease transmitted by sand flies) in animal models; and selects the most effective and safe candidates for continued refinement and possible clinical testing. This effort also conducts studies to investigate new candidate vaccines for preventing malaria and selects the best candidate(s) for continued refinement. A highly effective vaccine would reduce or eliminate the use of anti-malarial drugs and would minimize the progression and impact of drug resistance to current/future drugs. In FY17 the Drugs to Prevent/Treat Parasitic Diseases and Vaccines for Prevention of Malaria research areas are merged into Applied Research on drugs and vaccines against parasitic diseases.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2017
- Source ID
- 538c0b0eee89bd8bb200682b1f8433f8
Related Documents
- Root: Medical Technology